1102 related articles for article (PubMed ID: 10505802)
1. Use of bovine-derived anorganic bone associated with guided tissue regeneration in intrabony defects. Six-month evaluation at re-entry.
Batista EL; Novaes AB; Simonpietri JJ; Batista FC
J Periodontol; 1999 Sep; 70(9):1000-7. PubMed ID: 10505802
[TBL] [Abstract][Full Text] [Related]
2. Guided tissue regeneration associated with bovine-derived anorganic bone in mandibular class II furcation defects. 6-month results at re-entry.
Simonpietri-C JJ; Novaes AB; Batista EL; Filho EJ
J Periodontol; 2000 Jun; 71(6):904-11. PubMed ID: 10914793
[TBL] [Abstract][Full Text] [Related]
3. Combined periodontal regenerative technique in human intrabony defects by collagen membranes and anorganic bovine bone. A controlled clinical study.
Paolantonio M
J Periodontol; 2002 Feb; 73(2):158-66. PubMed ID: 11895280
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of a collagen membrane with and without bone grafts in treating periodontal intrabony defects.
Chen CC; Wang HL; Smith F; Glickman GN; Shyr Y; O'Neal RB
J Periodontol; 1995 Oct; 66(10):838-47. PubMed ID: 8537865
[TBL] [Abstract][Full Text] [Related]
5. Effect of platelet-rich plasma on the healing of intrabony defects treated with Beta tricalcium phosphate and expanded polytetrafluoroethylene membranes.
Döri F; Huszár T; Nikolidakis D; Tihanyi D; Horváth A; Arweiler NB; Gera I; Sculean A
J Periodontol; 2008 Apr; 79(4):660-9. PubMed ID: 18380559
[TBL] [Abstract][Full Text] [Related]
6. Bioabsorbable membrane and bioactive glass in the treatment of intrabony defects in patients with generalized aggressive periodontitis: results of a 5-year clinical and radiological study.
Mengel R; Schreiber D; Flores-de-Jacoby L
J Periodontol; 2006 Oct; 77(10):1781-7. PubMed ID: 17032123
[TBL] [Abstract][Full Text] [Related]
7. Bioabsorbable membrane and bioactive glass in the treatment of intrabony defects in patients with generalized aggressive periodontitis: results of a 12-month clinical and radiological study.
Mengel R; Soffner M; Flores-de-Jacoby L
J Periodontol; 2003 Jun; 74(6):899-908. PubMed ID: 12887004
[TBL] [Abstract][Full Text] [Related]
8. Comparison of platelet-rich plasma, bovine porous bone mineral, and guided tissue regeneration versus platelet-rich plasma and bovine porous bone mineral in the treatment of intrabony defects: a reentry study.
Lekovic V; Camargo PM; Weinlaender M; Vasilic N; Kenney EB
J Periodontol; 2002 Feb; 73(2):198-205. PubMed ID: 11895286
[TBL] [Abstract][Full Text] [Related]
9. A surgical reentry study on the influence of platelet-rich plasma in enhancing the regenerative effects of bovine porous bone mineral and guided tissue regeneration in the treatment of intrabony defects in humans.
Camargo PM; Lekovic V; Weinlaender M; Divnic-Resnik T; Pavlovic M; Kenney EB
J Periodontol; 2009 Jun; 80(6):915-23. PubMed ID: 19485821
[TBL] [Abstract][Full Text] [Related]
10. Effect of platelet-rich plasma on the healing of intrabony defects treated with an anorganic bovine bone mineral: a pilot study.
Döri F; Kovács V; Arweiler NB; Huszár T; Gera I; Nikolidakis D; Sculean A
J Periodontol; 2009 Oct; 80(10):1599-605. PubMed ID: 19792848
[TBL] [Abstract][Full Text] [Related]
11. A comparative study utilizing open flap debridement with and without enamel matrix derivative in the treatment of periodontal intrabony defects: a 12-month re-entry study.
Froum SJ; Weinberg MA; Rosenberg E; Tarnow D
J Periodontol; 2001 Jan; 72(1):25-34. PubMed ID: 11210070
[TBL] [Abstract][Full Text] [Related]
12. A clinical comparison of a bovine-derived xenograft used alone and in combination with enamel matrix derivative for the treatment of periodontal osseous defects in humans.
Scheyer ET; Velasquez-Plata D; Brunsvold MA; Lasho DJ; Mellonig JT
J Periodontol; 2002 Apr; 73(4):423-32. PubMed ID: 11990444
[TBL] [Abstract][Full Text] [Related]
13. Five-year results of a prospective, randomized, controlled study evaluating treatment of intra-bony defects with a natural bone mineral and GTR.
Sculean A; Schwarz F; Chiantella GC; Donos N; Arweiler NB; Brecx M; Becker J
J Clin Periodontol; 2007 Jan; 34(1):72-7. PubMed ID: 17243997
[TBL] [Abstract][Full Text] [Related]
14. Surgical treatment of periodontal intrabony defects with calcium sulfate implant and barrier versus collagen barrier or open flap debridement alone: a 12-month randomized controlled clinical trial.
Paolantonio M; Perinetti G; Dolci M; Perfetti G; Tetè S; Sammartino G; Femminella B; Graziani F
J Periodontol; 2008 Oct; 79(10):1886-93. PubMed ID: 18834243
[TBL] [Abstract][Full Text] [Related]
15. Effects of pretreatment clinical parameters on bioactive glass implantation in intrabony periodontal defects.
Park JS; Suh JJ; Choi SH; Moon IS; Cho KS; Kim CK; Chai JK
J Periodontol; 2001 Jun; 72(6):730-40. PubMed ID: 11453234
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of a bioactive glass alloplast in treating periodontal intrabony defects.
Ong MM; Eber RM; Korsnes MI; MacNeil RL; Glickman GN; Shyr Y; Wang HL
J Periodontol; 1998 Dec; 69(12):1346-54. PubMed ID: 9926764
[TBL] [Abstract][Full Text] [Related]
17. Clinical comparison of an enamel matrix derivative used alone or in combination with a bovine-derived xenograft for the treatment of periodontal osseous defects in humans.
Velasquez-Plata D; Scheyer ET; Mellonig JT
J Periodontol; 2002 Apr; 73(4):433-40. PubMed ID: 11990445
[TBL] [Abstract][Full Text] [Related]
18. Effect of platelet-rich plasma on the healing of intrabony defects treated with an anorganic bovine bone mineral and expanded polytetrafluoroethylene membranes.
Döri F; Huszár T; Nikolidakis D; Arweiler NB; Gera I; Sculean A
J Periodontol; 2007 Jun; 78(6):983-90. PubMed ID: 17539709
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcomes after treatment of non-contained intrabony defects with enamel matrix derivative or guided tissue regeneration: a 12-month randomized controlled clinical trial.
Siciliano VI; Andreuccetti G; Siciliano AI; Blasi A; Sculean A; Salvi GE
J Periodontol; 2011 Jan; 82(1):62-71. PubMed ID: 20809859
[TBL] [Abstract][Full Text] [Related]
20. Generalizability of the added benefits of guided tissue regeneration in the treatment of deep intrabony defects. Evaluation in a multi-center randomized controlled clinical trial.
Tonetti MS; Cortellini P; Suvan JE; Adriaens P; Baldi C; Dubravec D; Fonzar A; Fourmousis I; Magnani C; Muller-Campanile V; Patroni S; Sanz M; Vangsted T; Zabalegui I; Pini Prato G; Lang NP
J Periodontol; 1998 Nov; 69(11):1183-92. PubMed ID: 9848527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]